Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
In our humanoid robotics department, we are seeking several outstanding humanoid robot developers and a technical purchaser to turn the idea into reality. This includes: Your mission & challenges Procurement of technically sophisticated components and assemblies (e.g.,